Key result
Surgery for intracardiac masses in 8 patients resulted in 1 postoperative death and 1 amputation, with no further mortality, complications, or recurrence in survivors over 0.5 to 5 years.
Observational (n=8)
Surgical resection of benign intracardiac masses yields favorable long-term outcomes, whereas malignant masses like angiosarcoma carry a high risk of early mortality.
Answers are grounded in this paper and cite their sources.
Surgical risks evident for malignant intracardiac masses; leaves open optimal strategies pending larger prospective data.
Between 1991 and 1998, 8 patients (mean age, 29.6 years) underwent surgery for an intracardiac mass. There were 2 hydatid cysts, 1 angiosarcoma, and 5 myxomas. One patient with myxoma underwent a Syme's amputation due to lower extremity ischemia caused by embolization. The patient with angiosarcoma died of cardiopulmonary failure on the 9th postoperative day. The surviving patients experienced no mortality, complications, or recurrence during follow-up of 0.5 to 5 years.
No takes yet. Share an insight, caveat, or question.
Taşdemir et al. (2000) conducted an observational in Intracardiac masses (n=8). Surgery was evaluated on Mortality, complications, or recurrence. Surgery for intracardiac masses in 8 patients resulted in 1 postoperative death and 1 amputation, with no further mortality, complications, or recurrence in survivors over 0.5 to 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: